Megabox raises $26.8 mil in bond sale amid vaccine optimism Cinema chain’s private bond sale comes a month after $17.8 mil bond offering
Translated by Ryu Ho-joung 공개 2021-04-15 08:27:07
이 기사는 2021년 04월 15일 08:11 thebell 에 표출된 기사입니다.
Megabox JoongAng, one of the major cinema chains in South Korea, has raised 30 billion won ($26.8 million) in a private bond sale, with optimism growing over a rebound in the theater market as the Covid-19 vaccines roll out.The two-year bonds were issued at 3%, with Hanyang Securities acting as the lead underwriter. The bond sale was structured for the brokerage firm to buy the entire offering before issuing short-term notes backed by the bonds.
The sale comes after Megabox JoongAng returned to the corporate bond market in more than a year by selling 20 billion won worth of securitized bonds last month.
The theater chain’s recent bond sales have been met with sufficient demand from investors thanks to optimism over the vaccine rollout, which could lead to a resurgence in theater attendance and an improvement in the company’s financial position.
Megabox JoongAng, formerly part of Orion Group, was founded in 1999. It was acquired by J Contentree and then was merged with the content company’s cinema chain Cinus in 2011. It has 50 theaters nationwide, with the third-largest market share behind CJ CGV and Lotte Cinema.
Like other movie theaters around the country, Megabox JoongAng was hit hard by the pandemic last year. It recorded an operating loss of 68.2 billion and net loss of 65.5 billion won on revenue of 104.5 billion won, which was down 68% year-on-year.
Megabox JoongAng was assigned a credit rating of BBB+ with a negative outlook by KIS Rating and Korea Rating. The local credit agencies viewed the collapsing box-office demand that continues to hurt the company’s financial condition as credit negative. The theater chain also faces challenges in the long term as more people watch movies on online streaming services and digital TVs.
“The company’s operating performance is unlikely to rebound in the near term, meaning the company is unlikely to reduce its financial burdens without an improvement in non-operating items,” said an official at KIS Rating. (Reporting by Su-jeong Kim)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
best clicks
최신뉴스 in 전체기사
-
- [2023 더벨 글로벌 투자 로드쇼-인도네시아]인니 정부, 친기업 정책 드라이브에 뜨거운 관심 '체감'
- [2023 더벨 글로벌 투자 로드쇼-인도네시아]"유망 스타트업 양성소, 글로벌 투자 거점 부상"
- [2023 더벨 글로벌 투자 로드쇼-인도네시아]"철저히 투자금융 관점서 봐야, 전략적 접근시 유리"
- [2023 더벨 글로벌 투자 로드쇼-베트남]신용보증기금, 중기 베트남 진출 지원에 팔 걷었다
- [2023 더벨 글로벌 투자 로드쇼-베트남]인프라·산업 투자 증가, 부동산 가격 상승 견인
- [2023 더벨 글로벌 투자 로드쇼-베트남]떠오르는 신규 투자처 '온실가스 감축 프로젝트'
- [2023 더벨 글로벌 투자 로드쇼-베트남]VITASK, 베트남 현지 기업 생산·기술력 개선 앞장
- [2023 더벨 글로벌 투자 로드쇼-베트남]급성장 '핀테크' 산업, 전자 결제·P2P·초단기 분야 각광
- [2023 더벨 글로벌 투자 로드쇼-베트남]진출 계획시 세무 접근 필요, '우대세율·감면' 활용해야 '득'
- [2023 더벨 글로벌 투자 로드쇼-베트남]한국이 투자 주춤할 때 태국은 과감히 '베팅'